Efficacy and safety of Artesunate for patients with IgA nephropathy: a multicenter, double-blind, randomized, placebo-controlled trial. Efficacy and safety of Artesunatefor patients with IgA nephropathy: a multicenter, double-blind, ran ...
Efficacy and safety of Artesunate for patients with IgA nephropathy: a multicenter, double-blind, randomized, placebo-controlled trial. Efficacy and safety of Artesunatefor patients with IgA nephropathy: a multicenter, double-blind, ran ...
IgA nephropathy
Group 1:Artesunate 100mg (50mg/Bid);Group 2:Artesunate 50mg (25mg/Bid);The control group:Placebo;
Dongzhimen Hospital, The First Affiliated Hospital of Beijing University of Chinese Medicine